Exact Mass: 333.0669
Exact Mass Matches: 333.0669
Found 39 metabolites which its exact mass value is equals to given mass value 333.0669,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
Bromodiphenhydramine
Bromodiphenhydramine is only found in individuals that have used or taken this drug. It is an ethanolamine antihistamine with antimicrobial property. Bromodiphenhydramine is used in the control of cutaneous allergies. Ethanolamine antihistamines produce marked sedation in most patientsBromodiphenhydramine competes with free histamine for binding at HA-receptor sites. This antagonizes the effects of histamine on HA-receptors, leading to a reduction of the negative symptoms brought on by histamine HA-receptor binding. R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AA - Aminoalkyl ethers C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
Meglitinide
C78276 - Agent Affecting Digestive System or Metabolism > C29711 - Anti-diabetic Agent > C98079 - Meglitinide Antidiabetic Agent D007004 - Hypoglycemic Agents
(R)-2-(((BENZYLOXY)CARBONYL)AMINO)-3-(4-CHLOROPHENYL)PROPANOIC ACID
3-(4-CHLORO-BENZOYLAMINO)-3-(4-METHOXY-PHENYL)-PROPIONIC ACID
6-BROMO-3-PHENYL-3,4,5,6-TETRAHYDRO-2H-[1,2]BIPYRAZINYL-3-YLAMINE
Dipyrone
N - Nervous system > N02 - Analgesics > N02B - Other analgesics and antipyretics > N02BB - Pyrazolones C78272 - Agent Affecting Nervous System > C241 - Analgesic Agent > C2198 - Nonnarcotic Analgesic D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002491 - Central Nervous System Agents > D000700 - Analgesics D000893 - Anti-Inflammatory Agents D018501 - Antirheumatic Agents D058633 - Antipyretics
GSK1059615
C274 - Antineoplastic Agent > C163758 - Targeted Therapy Agent > C2152 - Phosphatidylinositide 3-Kinase Inhibitor C274 - Antineoplastic Agent > C2189 - Signal Transduction Inhibitor > C129824 - Antineoplastic Protein Inhibitor C471 - Enzyme Inhibitor > C129825 - Antineoplastic Enzyme Inhibitor C274 - Antineoplastic Agent > C1742 - Angiogenesis Inhibitor C471 - Enzyme Inhibitor > C1404 - Protein Kinase Inhibitor
Thiazolidine, 3-(methylsulfonyl)-2-(2,4,5-trimethoxyphenyl)- (9CI)
(S)-2-(((BENZYLOXY)CARBONYL)AMINO)-3-(4-CHLOROPHENYL)PROPANOIC ACID
N-(4-TRIFLUOROMETHYL)PHENYL-3-TRIFLUOROMETHYLBENZAMIDE
N-[4-(TRIFLUOROMETHYL)PHENYL]-4-(TRIFLUOROMETHYL)BENZAMIDE
2-[[(2,4-Difluorophenyl)-2-oxiranyl]methyl]-1H-1,2,4-triazole methanesulfonate
1-(3-Bromo-5-methylpyridin-2-yl)-4-propylpiperazine hydrochloride
2-(4-AMINOPHENYL)-6-NITRO-1H-BENZO[DE]ISOQUINOLINE-1,3(2H)-DIONE
2-(3-Bromo-2-oxopropyl)-3-methoxy-1-piperidinecarboxylic acid 2-propenyl ester
N-(4-chloro-2-fluorophenyl)-6,7-dimethoxyquinazolin-4-amine
Ethanamine, 2-((R)-(4-bromophenyl)phenylmethoxy)-N,N-dimethyl-
2-{3-nitroanilino}-N-({5-nitro-2-furyl}methylene)acetohydrazide
Ethanamine, 2-((S)-(4-bromophenyl)phenylmethoxy)-N,N-dimethyl-
1-(5-Chloro-2,4-Dimethoxyphenyl)-3-(5-Cyanopyrazin-2-Yl)urea
d-[3-Hydroxy-2-methyl-5-phosphonooxymethyl-pyridin-4-ylmethyl]-n,o-cycloserylamide
(2R)-2,3-dihydroxypropyl (1S,2R,3R,4S,5S,6R)-2,3,4,5,6-pentahydroxycyclohexyl phosphate
3-Pyridinecarboxylic acid [2-(2-furanyl)-4-oxo-1-benzopyran-3-yl] ester
2-(1H-benzimidazol-2-ylthio)-N-(5-propyl-1,3,4-thiadiazol-2-yl)acetamide
2-Chloro-5-methyl-1-oxo-3-phenyl-4-pyrido[1,2-a]benzimidazolecarbonitrile
N-(1-cyano-4-piperidinyl)-4-(trifluoromethyl)benzenesulfonamide
bromazine
R - Respiratory system > R06 - Antihistamines for systemic use > R06A - Antihistamines for systemic use > R06AA - Aminoalkyl ethers C308 - Immunotherapeutic Agent > C29578 - Histamine-1 Receptor Antagonist
1-(sn-glycero-3-O-phosphonato)-1D-myo-inositol
An inositol phosphate oxoanion obtained by deprotonation of the free phosphate OH group of 1-(sn-glycero-3-phospho)-1D-myo-inositol; major species at pH 7.3.
